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A close-up view of a papule: an erythematous, telangiectatic rim surrounds an atro-
phic, porcelain-white center.Dear Editor,
A 41-year-old woman presented with a 2-year history of multi-
ple asymptomatic pea-sized papules with an erythematous, telan-
giectatic rim surrounding an atrophic, porcelain-white center on
the trunk and extremities (Figure 1). She had experienced abdom-
inal fullness and vomiting for 1 year. Histopathologic examination
of a skin biopsy from the left forearm revealed hyperkeratosis,
epidermal atrophy, vacuolar interface change, and wedge-shaped
dermal infarct in which nuclear dust and extravasation of erythro-
cytes were present (Figure 2A and B). The vessels in the infarcted
area showed focal obliteration and hyalinization (Figure 2C). Alcian
blue staining demonstrated abundant mucin deposition outlining
thewedge-shaped area of collagen degeneration (Figure 2D). Direct
immunoﬂuorescence was negative for IgG and C3. The clinical and
pathological manifestations were compatible with Degos disease.
Complete blood count with differential, hepatorenal, and coag-
ulation proﬁles, urinalysis and immunological fecal occult blood
test were all within normal limits except for an elevated erythro-
cyte sedimentation rate. Results of other laboratory examinations
were also within normal limits, including proﬁles of systemic lupus
erythematosus, systemic sclerosis, rheumatoid arthritis, der-
matomyositis, antiphospholipid syndrome, and vasculopathy. The
ophthalmologic examination revealed no conjunctival avascular
patches or telangiectasia. Magnetic resonance of the brain showed
no abnormalities. Esophagogastroduodenoscopy revealed reﬂux
esophagitis. Upper gastrointestinal and small intestine series
showed no evidence of bowel perforation, obstruction or abnormal
mucosal changes. A diagnosis of Degos disease, probably the benign
form, was made based on the clinical and pathological features. The
patient was treated with metoclopramide, aspirin, and dipyrida-
mole in outpatient follow-up. Some new cutaneous lesions
occurred and the old ones healed with atrophic scars. Although
she still suffered from abdominal fullness and vomiting, no intesti-
nal perforation, cerebrovascular accident, or other life-threatening
complications occurred during the following 6 months.
Degos disease is a rare thrombo-obliterative vasculopathy char-
acterized by pathognomonic atrophic porcelain-white papules
with a surrounding telangiectatic rose-colored rim.1 Skin lesions
usually precede systemic manifestations with the most common
affected organ systems being, in order, gastrointestinal, neurologic,
cardiac, and pulmonary systems.2 Ocular involvement, including
avascular conjunctival patches, telengiectatic vessels, and scleral
thinning, has also been described.3 The pathogenesis of the occlu-
sive vasculopathy with eventual tissue infarction, although not
clearly understood, may be related to coagulopathy, primary
dysfunction of the endothelial cells, and dysregulation of1027-8117/$ – see front matter Copyright  2013, Taiwanese Dermatological Associatio
http://dx.doi.org/10.1016/j.dsi.2013.06.005interferon-a and the membranolytic attack complex of the comple-
ment system.1,2
Degos disease is also known as malignant atrophic papulosis,
nomenclature of which puts emphasis on characteristic skin erup-
tions and potentially fatal course in most patients. However, a mi-
nority of patients have a rather benign course with skin-limited
disease, no systemic involvement and long-term survival.4 Degosn. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 2 (A) At scanning magniﬁcation, there is a wedge-shaped area of dermal infarction with overlying atrophic epidermis (hematoxylin and eosin; original magniﬁcation: 40). (B)
Nuclear dust and extravasation of erythrocytes are present in the wedge-shaped area. (hematoxylin and eosin; original magniﬁcation: 200). (C) The vessels in the infarcted area show
focal obliteration and hyalinization (hematoxylin and eosin; original magniﬁcation: 400). (D) Mucin deposition outlines thewedge-shaped degeneration of collagen (alcian blue, 40).
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tion for the disease entities. Warren et al proposed classifying
Degos disease into two forms: a classical variant, which was further
subclassiﬁed as autoimmune, coagulopathy-associated, and virus-
induced subtypes, and a benign cutaneous variant.5
Fewer than 40 cases of benign cutaneous Degos disease with
characteristic histopathology of skin biopsy and at least 6 months
of follow-up have been reported in the literature to date.2,6 It is
worth noting that systemic involvement could develop years after
the occurrence of the skin lesions referred to as benign cutaneous
Degos disease initially.1 Classical and benign cutaneous Degos dis-
ease share similar histopathologic features: Perivascular and peri-
adnexal lymphocytic inﬁltrate with a vacuolar interface, and
wedge-shaped degeneration of collagen.2 There is no deﬁnite clin-
ical, laboratory, or histopathologic indicator to predict the clinical
course and distinguish these two variants at the time of presenta-
tion. Wachter et al speculated the lack of occluded vessel could
be a hallmark of benign cutaneous Degos disease,7 but not all his-
topathology reports of cases support this hypothesis.
Due to the rarity of Degos disease and the high rates of treat-
ment failure for its classical variant, evidence-based efﬁcacy of
therapeutic modalities has been demonstrated in individual case
reports, but not in randomized controlled trials. The combination
of aspirin and dipyridamole or each alone has shown variable effec-
tiveness.1,2,6 In patients with progressive malignant atrophic papu-
losis, treatment with eculizumab, the monoclonal antibody to the
complement protein C5, demonstrated immediate efﬁcacy but
could not prevent further progression.1,2 Corticosteroids, generally
thought to be contraindicated, may worsen skin eruptions and has-
ten complications.1,6 Surgical intervention including laparotomy for
abdominal involvement has not been successful.6
Our patient, who had a 2-year history of characteristic skin
eruptions without signiﬁcant evidence of systemic involvement,
was regarded as benign cutaneous Degos disease. Therefore, der-
matologists should be alert to the possibility of Degos disease in
patients who present with pathognomonic skin lesions. Patients
with benign cutaneous Degos disease may have a fair prognosiswith long-term survival, but they require regular follow-up due
to the possibility of future systemic involvement.
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